Stock Analysis on Net
Stock Analysis on Net

Gilead Sciences Inc. (NASDAQ:GILD)

Common-Size Income Statement
Quarterly Data

Beginner level

Gilead Sciences Inc., common-size consolidated income statement (quarterly data)

Microsoft Excel LibreOffice Calc
3 months ended: Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Product sales 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost of goods sold -17.57 -21.00 -17.72 -29.04 -18.76 -17.83 -18.40 -27.64 -19.91 -21.59 -20.02 -21.52 -16.12 -15.98 -15.01 -14.90 -15.25 -11.29 -15.53 -12.63 -12.96 -12.28 -11.91
Gross profit on product sales 82.43% 79.00% 82.28% 70.96% 81.24% 82.17% 81.60% 72.36% 80.09% 78.41% 79.98% 78.48% 83.88% 84.02% 84.99% 85.10% 84.75% 88.71% 84.47% 87.37% 87.04% 87.72% 88.09%
Royalty, contract and other revenues 1.29 1.50 1.48 1.43 1.60 1.39 1.56 2.01 2.58 1.95 1.74 1.92 1.72 1.35 2.01 1.44 1.28 1.63 1.47 1.15 1.02 1.45 2.55
Research and development expenses -17.83 -25.64 -18.36 -32.76 -90.46 -20.69 -20.33 -34.32 -17.21 -21.52 -18.74 -19.70 -12.32 -12.26 -14.60 -16.74 -15.41 -19.40 -16.47 -9.00 -9.05 -10.07 -9.40
Acquired in-process research and development expenses -18.03 -89.28 -1.77 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Selling, general and administrative expenses -17.03 -24.45 -19.68 -20.77 -19.07 -19.53 -19.81 -19.91 -17.38 -17.69 -19.94 -21.45 -13.73 -12.73 -13.33 -13.75 -11.22 -11.63 -8.92 -12.68 -11.00 -9.99 -8.71
Income (loss) from operations 30.82% -58.87% 43.94% 18.86% -26.70% 43.34% 43.02% 20.14% 48.08% 41.16% 43.05% 39.25% 59.54% 60.37% 59.07% 56.06% 59.41% 59.31% 60.55% 66.85% 68.02% 69.11% 72.53%
Interest expense -3.63 -4.74 -4.41 -4.19 -4.53 -4.42 -4.88 -4.52 -4.84 -4.80 -5.80 -5.09 -4.55 -3.82 -4.09 -3.67 -3.27 -2.97 -2.99 -2.74 -2.01 -1.72 -2.07
Other income (expense), net -14.48 4.93 -2.89 18.13 4.02 4.07 7.06 2.27 5.59 1.30 3.40 2.26 2.34 1.85 1.74 1.94 1.61 1.15 1.05 0.55 0.63 0.43 0.28
Income (loss) before income taxes 12.71% -58.67% 36.64% 32.80% -27.21% 42.98% 45.19% 17.88% 48.84% 37.65% 40.65% 36.42% 57.34% 58.40% 56.72% 54.32% 57.74% 57.50% 58.61% 64.66% 66.64% 67.82% 70.75%
Income tax (expense) benefit -7.27 -7.36 -8.51 13.60 6.04 -9.54 -7.35 -17.83 -10.36 -4.82 -9.88 -102.14 -14.98 -14.85 -14.40 -11.38 -12.84 -11.79 -12.17 -8.94 -10.72 -12.48 -12.25
Net income (loss) 5.44% -66.04% 28.13% 46.39% -21.17% 33.44% 37.85% 0.05% 38.48% 32.83% 30.77% -65.72% 42.36% 43.56% 42.32% 42.95% 44.90% 45.71% 46.44% 55.71% 55.92% 55.34% 58.50%
Net (income) loss attributable to noncontrolling interest 0.11 0.14 0.24 0.12 0.05 0.09 0.13 0.00 -0.04 -0.04 -0.02 -0.50 0.09 0.06 0.05 0.12 0.07 0.00 -0.01 -0.02 0.10 -0.06 0.01
Net income (loss) attributable to Gilead 5.54% -65.90% 28.37% 46.51% -21.12% 33.53% 37.98% 0.05% 38.44% 32.80% 30.75% -66.22% 42.46% 43.61% 42.37% 43.07% 44.97% 45.71% 46.43% 55.69% 56.02% 55.28% 58.51%

Based on: 10-Q (filing date: 2020-11-04), 10-Q (filing date: 2020-08-06), 10-Q (filing date: 2020-05-06), 10-K (filing date: 2020-02-25), 10-Q (filing date: 2019-11-05), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-08), 10-K (filing date: 2019-02-26), 10-Q (filing date: 2018-11-06), 10-Q (filing date: 2018-08-06), 10-Q (filing date: 2018-05-09), 10-K (filing date: 2018-02-27), 10-Q (filing date: 2017-11-07), 10-Q (filing date: 2017-08-07), 10-Q (filing date: 2017-05-10), 10-K (filing date: 2017-02-27), 10-Q (filing date: 2016-11-07), 10-Q (filing date: 2016-08-05), 10-Q (filing date: 2016-05-06), 10-K (filing date: 2016-02-24), 10-Q (filing date: 2015-11-04), 10-Q (filing date: 2015-08-05), 10-Q (filing date: 2015-05-08).

Income statement item Description The company
Income (loss) from operations The net result for the period of deducting operating expenses from operating revenues. Gilead Sciences Inc.’s income (loss) from operations as a percentage of product sales decreased from Q1 2020 to Q2 2020 but then increased from Q2 2020 to Q3 2020 not reaching Q1 2020 level.
Income (loss) before income taxes Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Gilead Sciences Inc.’s income (loss) before income taxes as a percentage of product sales decreased from Q1 2020 to Q2 2020 but then increased from Q2 2020 to Q3 2020 not reaching Q1 2020 level.
Net income (loss) attributable to Gilead The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Gilead Sciences Inc.’s net income (loss) attributable to Gilead as a percentage of product sales decreased from Q1 2020 to Q2 2020 but then increased from Q2 2020 to Q3 2020 not reaching Q1 2020 level.